Related references
Note: Only part of the references are listed.The clinical effectiveness and cost-effectiveness of second-eye cataract surgery: a systematic review and economic evaluation
[Anonymous]
HEALTH TECHNOLOGY ASSESSMENT (2014)
Simultaneous detection of 22 toxic plant alkaloids (aconitum alkaloids, solanaceous tropane alkaloids, sophora alkaloids, strychnos alkaloids and colchicine) in human urine and herbal samples using liquid chromatography-tandem mass spectrometry
Sau Wah Ng et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2013)
Cytisine and the failure to market and regulate for human health
Paul Aveyard et al.
THORAX (2013)
Efficacy of cytisine in helping smokers quit: systematic review and meta-analysis
Peter Hajek et al.
THORAX (2013)
Cytisine, the world's oldest smoking cessation aid
Judith J. Prochaska et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Comparative analysis of quinolizidine alkaloids from different parts of Sophora alopecuroides seeds by UPLC-MS/MS
Hanqing Wang et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2012)
Placebo-Controlled Trial of Cytisine for Smoking Cessation
Robert West et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Pre-clinical properties of the α4β2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence
H. Rollema et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Population pharmacokinetic analysis of varenicline in adult smokers
Patanjali Ravva et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Pharmacokinetics, Safety, and Tolerability of Varenicline in Healthy Adolescent Smokers: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study
Helene Faessel et al.
CLINICAL THERAPEUTICS (2009)
Cytisine-Based Nicotinic Partial Agonists as Novel Antidepressant Compounds
Yann S. Mineur et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Avoidable global cancer deaths and total deaths from smoking
Prabhat Jha
NATURE REVIEWS CANCER (2009)
Nicotinic receptor partial agonists as novel compounds for the treatment of smoking cessation
Piotr Tutka
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2008)
Simultaneous determination of thirteen plant alkaloids in a human specimen by SPE and HPLC
Joerg Pietsch et al.
JOURNAL OF SEPARATION SCIENCE (2008)
Effect of human renal cationic transporter inhibition on the pharmacokinetics of varenicline, a new therapy for smoking cessation:: An in vitro-in vivo study
B. Feng et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
A Double-Blind, Randomised, Placebo-Controlled Trial of Cytisine for Smoking Cessation in Medium-Dependent Workers
Denis Vinnikov et al.
JOURNAL OF SMOKING CESSATION (2008)
Detection and validated quantification of toxic alkaloids in human blood plasma - comparison of LC-APCI-MS with LC-ESI-MS/MS
Jochen Beyer et al.
JOURNAL OF MASS SPECTROMETRY (2007)
An uncontrolled trial of cytisine (Tabex) for smoking cessation
Witold Zatonski et al.
TOBACCO CONTROL (2006)
Pharmacokinetics, safety, and tolerability after single and multiple oral doses of varenicline in elderly smokers
Aaron H. Burstein et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Single-dose pharmacokinetics of varenicline, a selective nicotinic receptor partial agonist, in healthy smokers and nonsmokers
Helene M. Faessel et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation -: A randomized controlled trial
David Gonzales et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation -: A randomized controlled trial
Douglas E. Jorenby et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Metabolism and disposition of varenicline, a selective alpha 4 beta 2 acetylcholine receptor partial agonist, in vivo and in vitro
RS Obach et al.
DRUG METABOLISM AND DISPOSITION (2006)
A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors
J de Leon et al.
SCHIZOPHRENIA RESEARCH (2005)
Determination of quinolizidine alkaloids in Sophora tonkinensis by HPCE
PL Ding et al.
PHYTOCHEMICAL ANALYSIS (2005)
Shape of the relapse curve and long-term abstinence among untreated smokers
JR Hughes et al.
ADDICTION (2004)
Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies
R Peto et al.
BRITISH MEDICAL JOURNAL (2000)
Share Paper
